CurveBeam AI Limited (ASX: CVB) — Perfil da empresa, notícias e dados financeiros
CurveBeam AI Limited is a medical technology company that develops and commercializes advanced weight-bearing cone beam computed tomography imaging systems and artificial intelligence diagnostic software for orthopedic care.
CurveBeam AI Limited
CurveBeam AI Limited is a medical technology company that develops and commercializes advanced weight-bearing cone beam computed tomography imaging systems and artificial intelligence diagnostic software for orthopedic care. The company provides specialized three-dimensional scanners that allow specialists to evaluate bone structure, joint alignment, and functional biomechanics while patients are standing under physiological load. Its offerings cover imaging systems for lower extremities and distal upper extremities, paired with cloud-based software tools for diagnostic analysis, bone density assessment, and surgical workflow integration.
Resumo
Operações
Produtos e/ou serviços de CurveBeam AI Limited
- Lower Extremity Weight-Bearing CT Systems: HiRise provides three-dimensional cone beam CT imaging for the foot, ankle, knee, and hip while patients stand under full body weight, enabling orthopedic specialists to evaluate joint alignment and anatomical relationships under functional load.
- Distal Upper Extremity CT Scanners: InReach delivers targeted high-resolution three-dimensional CT imaging for distal upper extremities, covering the hand, wrist, and elbow, to assist orthopedic clinicians in assessing complex osseous fractures, joint alignment, and localized trauma without full-body exposure.
- Foot and Ankle CT Systems: LineUp and pedCAT systems offer compact bilateral weight-bearing cone beam CT scans dedicated to foot and ankle evaluation, capturing standing three-dimensional osseous anatomy directly at the point of care for orthopedic clinics and surgical practices.
- Diagnostic Imaging Software: CubeVue software provides three-dimensional visualization, multi-planar reconstruction, and image management capabilities, allowing clinicians to interpret weight-bearing CT datasets, simulate surgical outcomes, and share diagnostic files across healthcare networks.
- Automated 3D Measurement Tools: Axiometrics and TALAS tools calculate precise three-dimensional anatomical angles and alignment metrics automatically from cone beam CT scans, supporting standardization of diagnostic metrics for lower-limb biomechanical assessment and deformity correction planning.
- Bone Density and AI Software Pipeline: BoneVue and cloud-based diagnostic modules utilize artificial intelligence algorithms to measure bone mineral density and analyze microstructural bone health from weight-bearing CT scans, supporting early detection of osteoporosis and preoperative bone quality evaluation.
equipe executiva do CurveBeam AI Limited
- Gregory Wayne BrownCEO, MD & Director
- Ura Phillip Stephen AucklandCFO & Company Secretary
- Arun Bahadur SinghCOO, CTO, President of US & Europe Division and Executive Director
- Aloys MbalaCo-Founder
- Ali GhasemzadehCo-Founder
- S. Turner DeanChief Sales Officer
- Vinti SinghVice President of Marketing
- Yu PengChief Technology Officer (Artificial Intelligence) & Executive Director
- Ego SeemanMedical Director - Endocrinology
Últimas notícias sobre a CurveBeam AI Limited
Comunicados recentes
O que a CurveBeam AI Limited (CVB) comunicou ao mercado, do mais recente para o mais antigo.
- Change in substantial holding - Intellivision Holdings
- Change in substantial holding - Arun & Susmita Singh
- CVB Achieves NMPA Approval for HiRise in ChinaFato relevante
- Trading HaltFato relevante
- Cleaning Notice for Shortfall Overflow Placement - Part B
- Notification regarding unquoted securities - CVB
- Application for quotation of securities - CVB
- Date of 2026 Annual General Meeting
Principais indicadores financeiros
Resultados divulgados pela CurveBeam AI Limited, em AUD.
- Cap. de mercado
- 6,6 mi
- Receita (TTM)
- 8,7 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.0
- Dividend yield
- —
- Margem de lucro
- -217.3%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 8,7 mi | -20,4 mi | -18,8 mi | |
| 12,1 mi | -16,8 mi | -16,8 mi | |
| 6,5 mi | -23,1 mi | -23,1 mi | |
| 8,1 mi | -52 mi | -52 mi |